Vaccitech PLC, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapies and vaccines, announced Tuesday that it has acquired Avidea Technologies Inc ...

A conference call and webcast will be held on December 14, 2021, at 8:30 a.m. EST (1:30 p.m. GMT). The webcast link and presentation can be found on the Events section of the Vaccitech website here.

UK biopharmaceutical company Vaccitech has acquired Johns Hopkins spinout Avidea Technologies in a deal valued at $40 million. Vaccitech developed the technology behind the AstraZeneca COVID-19 ...

AVidea Group will bring its Safe Zone Gunfire Detector to CES 2019, designed to analyze active shooter situations and automatically communicate with first responders, school administrators, parents ...

The co-founders of Avidea were creating vaccines before it was cool. Now, their passion for protecting people against the world’s most dangerous diseases continues to propel the Baltimore-based ...

A British biopharmaceutical company and vaccine maker has acquired Avidea Technologies, a biotechnology tenant in Johns Hopkins University’s FastForward incubation program, for $40 million.

BALTIMORE, June 14, 2021 /PRNewswire/ -- Avidea Technologies, Inc. ("Avidea"), a biotechnology company developing 'precision' immunotherapies for cancer and autoimmunity, announced today the ...

A conference call and webcast will be held on December 14, 2021, at 8:30 a.m. EST (1:30 p.m. GMT). The webcast link and presentation can be found on the Events section of the Vaccitech website here.

OXFORD, United Kingdom, and BALTIMORE, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel ...

OXFORD, United Kingdom, and BALTIMORE, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel ...